Instead of squawking nonsense at me (for my long term unchanged position) perhaps consider reaching out the to company and asking:
Why did it take 18 months to recruit a patient in p1b? Why was the trial halted in 2024 with no updates provided to shareholders since 2023? Why didn't management investigate low dose mono/combination therapy given the data produced in p1a?
IMU Price at posting:
1.5¢ Sentiment: Sell Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)